Skip to content
Maimon Research LLC

  • Home
  • Distance Education Programs
  • Programs For Purchase
  • Working Papers
  • Questions and Answers
Latest Working Papers

More Covid-19 Nonsense: The ICER modelled threshold price benchmarks for Remdesivir

October 22, 2020 Dr Paul Langely 747 Views

Paul C. Langley, Ph.D., Adjunct Professor College of Pharmacy, University of Minnesota, MN

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.
Working-Paper-No.-22-October-2020Download
  • Formulary Design, Fair Price and Fair Access for Pharmaceuticals:The Institute for Clinical and Economic Review and Office of Health Economics White Paper Falls at the First Hurdle
  • Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission Guidelines

DIRECT LINKS

  • LATENT CONSTRUCTS
  • RASCH POSSESSION
  • RASCH NUMBER LINE
  • NUMERICAL STORYTELLING
  • OBJECTIVE KNOWLEDGE
  • LOGIT RATIO SCALE
  • IMPOSSIBLE QALY
  • IMPOSSIBLE REFERENCE CASE
  • VALUE CLAIMS
  • CHEERS 2022 GUIDELINE

Most Viewed Working Papers

  • CORE VALUE CLAIMS, PROTOCOLS AND FORMULARY EVALUATIONS
  • NOTHING TO CHEER ABOUT: ENDORSING IMAGINARY ECONOMIC EVALUATIONS
  • AN ORDINAL OVERSIGHT: ABANDONING THE TUFTS
  • FUNDAMENTAL MEASUREMENT AND THERAPY RESPONSE
  • VALUE CLAIMS AND THE NEW START IN RARE DISEASE
  • REJECTING PSEUDOSCIENCE: TEN COMMANDMENTS
  • EVIDENTIARY STANDARDS FOR PATIENT-CENTRIC CORE IMPACT
  • DAMAGED GOODS: IMAGINARY ICER VALUE ASSESSMENTS
  • MEASUREMENT AND RESPONSE TO THERAPY
Copyright © 2025 Maimon Research LLC. All rights reserved.
Privacy Policy